Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Opko Health Inc | 19 |
| 2 | Poseidon Medical Inc | 13 |
| 3 | Medtronic PLC | 12 |
| 4 | Lakefront Biotherapeutics NV | 9 |
| 5 | Zurich Universität | 7 |
| 6 | 9 Meters Biopharma Inc | 5 |
| 7 | GSK PLC | 5 |
| 8 | Pfizer Inc | 5 |
| 9 | Roche Holding AG | 5 |
| 10 | Ashland Inc | 4 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 157 |
| 2 | A61K | Medicinal preparations | 143 |
| 3 | C07K | Peptides | 41 |
| 4 | C12N | Microorganisms, enzymes | 39 |
| 5 | G01N | Investigating / analysing materials | 39 |
| 6 | C07D | Heterocyclic compounds | 33 |
| 7 | A61L | Sterilising / disinfecting materials | 20 |
| 8 | A61M | Devices for introducing media into the body | 16 |
| 9 | C12Q | Measuring/testing involving enzymes | 16 |
| 10 | A61F | 15 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof | 2013 | Fortress Biotech Inc | 132 |
| Tumor necrosis factor receptor 2 | 2004 | Oruka Therapeutics Inc | 177 |
| ANTI-INFECTION AUGMENTATION FOAMABLE COMPOSITIONS AND KIT AND USES THEREOF | 2008 | 133 | |
| HIGH MANNOSE GLYCANS | 2011 | Johnson and Johnson | 109 |
| ANTIBIOTIC KIT AND COMPOSITION AND USES THEREOF | 2007 | 124 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Yusuf A. Hannun | Medical University of South Carolina | 8 |
| 2 | Lina M. Obeid | Ralph H. Johnson VA Medical Center | 6 |
| 3 | Alfred H. Merrill | Georgia Institute of Technology | 4 |
| 4 | Besim Öğretmen | Medical University of South Carolina | 4 |
| 5 | Kenji Chiba | Tanabe Pharma Corporation (Japan) | 4 |
| 6 | Tae‐Sik Park | Pfizer (United States) | 4 |
| 7 | Brett Garner | UNSW Sydney | 4 |
| 8 | Woojin S. Kim | Neuroscience Research Australia | 4 |
| 9 | Raghubir P. Sharma | University of Georgia | 4 |
| 10 | Victor J. Johnson | University of Georgia | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Ceramide-mediated Macroautophagy Involves Inhibition of Protein Kinase B and Up-regulation of Beclin 1 | 2004 | 458 | Lipid Membrane Structure and Behavior |
| Ceramide is a cardiotoxin in lipotoxic cardiomyopathy | 2008 | 409 | Sphingolipid Metabolism and Signaling |
| De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells | 2002 | 337 | Lipid Membrane Structure and Behavior |
| Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome | 2009 | 295 | Sphingolipid Metabolism and Signaling |
| Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-Deoxysphinganine | 2008 | 239 | Polysaccharides and Plant Cell Walls |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of this compound?
Which companies hold the most patents related to this compound?
What research areas are most frequently patented for this compound?
Who are the most prolific researchers publishing on this compound?
What are the major research topics associated with publications on this compound?